These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29964225)

  • 1. Mary Hewitt Loveless, MD: The origin of venom immunotherapy.
    Galli SJ
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):268-271. PubMed ID: 29964225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J; Golden DBK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuation of venom immunotherapy.
    Golden DB
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):703-4. PubMed ID: 9802387
    [No Abstract]   [Full Text] [Related]  

  • 5. Loveless on wasp venom allergy and immunity. Part 2. The contribution of Dr Mary Hewitt Loveless to the management of allergy to insect stings.
    Valentine MD
    J Allergy Clin Immunol; 2003 Dec; 112(6):1252-4. PubMed ID: 14657896
    [No Abstract]   [Full Text] [Related]  

  • 6. [Highly purified toxin extracts for desensitization. Insect-sting allergy: a causal treatment is possible].
    MMW Munch Med Wochenschr; 1979 Aug; 121(34):1057. PubMed ID: 114755
    [No Abstract]   [Full Text] [Related]  

  • 7. Depot extracts for rush venom immunotherapy: A new therapeutic opportunity for Hymenoptera sting allergy.
    Pucci S; Ciccarelli F; De Pasquale T; Illuminati I; D'Alò S
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):376-377. PubMed ID: 29908318
    [No Abstract]   [Full Text] [Related]  

  • 8. In conversation with Mary Hewitt Loveless, M.D.. Interview by Sheldon G. Cohen.
    Loveless MH
    Allergy Proc; 1989; 10(2):153-5. PubMed ID: 2661329
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wasp and bee venom allergy].
    Knulst AC; de Maat-Bleeker F; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):889-92. PubMed ID: 9623183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of national guidelines on venom immunotherapy practice in the United Kingdom.
    Diwakar L; Ewan P; Huber PA; Clark A; Nasser S; Krishna MT
    Clin Exp Allergy; 2016 May; 46(5):749-53. PubMed ID: 26989871
    [No Abstract]   [Full Text] [Related]  

  • 11. Stinging insect allergy and venom immunotherapy.
    Gupta P; Greenberger PA
    Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F; Przybilla B
    J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wasp Venom Immunotherapy in a Patient With Immune-Mediated Inflammatory Central Nervous System Disease: Is it Safe?
    Nittner-Marszalska M; Kowal A; Szewczyk P; Guranski K; Ejma M
    J Investig Allergol Clin Immunol; 2017; 27(2):127-129. PubMed ID: 28398199
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Hymenoptera venom allergy compared with real-life stings: Are we doing our best?
    Pecoraro L; Giovannini M; Mori F; Saretta F; Barni S; Castagnoli R; Arasi S; Mastrorilli C; Liotti L; Caminiti L; Novembre E;
    Clin Exp Allergy; 2021 Feb; 51(2):209-211. PubMed ID: 33617014
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
    Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 20. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.